1 | (2)-epigallocatechin-3-gallate (EGCG) | 2件: Epigallocatechin Epigallocatechin, Epigallocatechin gallate | - | - | - | 1件: 8 8 |
2 | 18F-FDG | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 13件: 5 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300 |
3 | 20 mg BID of PF-02545920 | - | - | - | - | 1件: 8 8 |
4 | 20mg daily citalopram | 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
5 | 5-Chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-oxo-N-phenyl-3-quinolinecarboxamide sodium | - | - | - | - | 1件: 8 8 |
6 | [123I]MNI-420 | - | - | - | - | 2件: 6 6, 8 |
7 | [18F]FPEB | - | - | - | - | 3件: 6 6, 8, 206 |
8 | ACR16 | - | - | - | - | 1件: 8 8 |
9 | ACR16 10 mg | - | - | - | - | 1件: 8 8 |
10 | ACR16 22.5 mg | - | - | - | - | 1件: 8 8 |
11 | ACR16 45 mg | - | - | - | - | 1件: 8 8 |
12 | ACR16 hydrochloride, ASP2314 hydrochloride, FR310826 | - | - | - | - | 1件: 8 8 |
13 | ADENO-ASSOCIATED VIRUS SEROTYPE 5 ENCODING A MICRORNA TARGETED TO HUMAN HUNTINGTIN GENE | - | - | - | - | 1件: 8 8 |
14 | AFQ056 | - | - | - | - | 3件: 6 6, 8, 206 |
15 | Alprazolam | 1件: Alprazolam Alprazolam | 1件: D00225
D00225
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 8 8, 75 |
16 | AMANTADINE | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 |
17 | AMT | - | - | - | - | 4件: 8 8, 46, 97, 321 |
18 | AMT-130 | - | - | - | - | 1件: 8 8 |
19 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
20 | ANX005 | - | - | - | - | 3件: 2 2, 8, 61 |
21 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: D02574
D02574
,
D07473
| 1件: SLC6A2 SLC6A2 💬 | 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 |
22 | Autologous Stem Cell | - | - | - | - | 1件: 8 8 |
23 | Benerva | - | - | - | - | 1件: 8 8 |
24 | Bevantolol | 1件: Bevantolol Bevantolol | - | - | - | 1件: 8 8 |
25 | BEVANTOLOL HYDROCHLORIDE | 1件: Bevantolol Bevantolol | - | - | - | 1件: 8 8 |
26 | BioStamp nPoint device | - | - | - | - | 1件: 8 8 |
27 | BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 5件: 2 2, 8, 10, 13, 20 |
28 | Biotina | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 2件: 8 8, 13 |
29 | Blood sample | - | - | - | - | 18件: 8 8, 13, 46, 49, 51, 53, 61, 65, 66, 84, 96, 97, 107, 127, 235, 274, 288, 299 |
30 | BN82451B | - | - | - | - | 1件: 8 8 |
31 | BN8251B | - | - | - | - | 1件: 8 8 |
32 | Branaplam | 1件: Branaplam Branaplam | - | - | - | 2件: 3 3, 8 |
33 | Bupropion | 1件: Bupropion Bupropion | 3件: D00817
D00817
,
D07591
,
D07938
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
34 | Calvan® 100 mg | - | - | - | - | 1件: 8 8 |
35 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
36 | CBD | - | - | - | - | 12件: 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
37 | Cellavita HD Higher dose | - | - | - | - | 1件: 8 8 |
38 | Cellavita HD Lower Dose | - | - | - | - | 1件: 8 8 |
39 | Cellavita-HD | - | - | - | - | 1件: 8 8 |
40 | Citalopram | 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
41 | CKD-504 | - | - | - | - | 1件: 8 8 |
42 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215 |
43 | CoQ10 | - | - | - | - | 3件: 5 5, 6, 8 |
44 | Creatine | 1件: Creatine Creatine | - | - | - | 16件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
45 | Creatine Monohydrate | 1件: Creatine Creatine | - | - | - | 4件: 2 2, 8, 113, 156 |
46 | CYSTAGON | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 3件: 8 8, 19, 299 |
47 | Cysteamine | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 4件: 8 8, 19, 21, 299 |
48 | Cysteamine Bitartrate | 1件: Cysteamine Cysteamine | 2件: D03634
D03634
,
D03635
| - | - | 4件: 8 8, 19, 21, 299 |
49 | Deep Brain Stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
50 | Delta-9-tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 3件: 8 8, 13, 36 |
51 | Delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) | 2件: Cannabidiol Cannabidiol, Dronabinol | 2件: D00306
D00306
,
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 8 8 |
52 | Deutetrabenazine | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
53 | Deutetrabenazine Oral Tablet [Austedo] | 1件: Deutetrabenazine Deutetrabenazine | 1件: D10701
D10701
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
54 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
55 | Dextromethorphan/quinidine 20mg/10mg (DM/Q 20mg/10mg) | 2件: Dextromethorphan Dextromethorphan, Quinidine | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 8 8 |
56 | Diagnostic Test: 11C-UCB-J PET-CT | - | - | - | - | 1件: 8 8 |
57 | Diagnostic Test: 18F-FDG PET-MR | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 1件: 8 8 |
58 | Digoxin | 1件: Digoxin Digoxin | 1件: D00298
D00298
| 4件: ATP1A1 ATP1A1, ATP1A2, ATP1A3, ATP1A4 💬 | 18件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Bile secretion, Carbohydrate digestion and absorption, Cardiac muscle contraction, Endocrine and other factor-regulated calcium reabsorption, Gastric acid secretion, Insulin secretion, Mineral absorption, Pancreatic secretion, Protein digestion and absorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Thyroid hormone signaling pathway, Thyroid hormone synthesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 8 8, 46, 210 |
59 | Dimebon | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
60 | Dimebon (latrepirdine) | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
61 | Dimebon + Dextromethorphan | 2件: Dextromethorphan Dextromethorphan, Latrepirdine | 4件: D00848
D00848
,
D03742
,
D03744
,
D09917
| 7件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
62 | Dimebon + Ketoconazole | 2件: Ketoconazole Ketoconazole, Latrepirdine | 2件: D00351
D00351
,
D09917
| 7件: ACHE ACHE, CYP17A1, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 28件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Ovarian steroidogenesis, Pathways of neurodegeneration - multiple diseases, Prion disease, Prolactin signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Steroid hormone biosynthesis, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
63 | Dimebon + Omeprazole | 2件: Latrepirdine Latrepirdine, Omeprazole | 5件: D00455
D00455
,
D01207
,
D05259
,
D05261
,
D09917
| 8件: ACHE ACHE, ATP4A, ATP4B, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 26件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Dopaminergic synapse, Gastric acid secretion, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxidative phosphorylation, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
64 | Dimebon alone | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
65 | Dimebon Dihydrochloride | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
66 | Dimebon IR | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
67 | Dimebon IR Tablet | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
68 | Dimebon MR1 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
69 | Dimebon MR2 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
70 | Dimebon MR3 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
71 | Dimebon MR4 | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
72 | Dimebon Transdermal | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
73 | Divalproex | - | - | - | - | 1件: 8 8 |
74 | DM | - | - | - | - | 2件: 6 6, 8 |
75 | EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
76 | EPA | - | - | - | - | 6件: 8 8, 46, 48, 49, 113, 301 |
77 | Epigallocatechin | 1件: Epigallocatechin Epigallocatechin | - | - | - | 5件: 8 8, 13, 28, 85, 113 |
78 | Ethyl Icosapent | 1件: Icosapent Icosapent | 1件: D08061
D08061
| - | - | 1件: 8 8 |
79 | Ethyl-EPA | 1件: Icosapent ethyl Icosapent ethyl | 1件: D01892
D01892
| - | - | 1件: 8 8 |
80 | Ethyl-EPA (Miraxion™) | 1件: Icosapent ethyl Icosapent ethyl | 1件: D01892
D01892
| - | - | 1件: 8 8 |
81 | Ethyl-Icosapent | 1件: Icosapent Icosapent | 1件: D08061
D08061
| - | - | 1件: 8 8 |
82 | Fenofibrate | 1件: Fenofibrate Fenofibrate | 1件: D00565
D00565
| 1件: PPARA PPARA 💬 | 10件: Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 5件: 8 8, 79, 93, 94, 265 |
83 | Graft intracerebral of foetal neurons | - | - | - | - | 1件: 8 8 |
84 | GSK356278 | - | - | - | - | 1件: 8 8 |
85 | Haloperidol | 1件: Haloperidol Haloperidol | 2件: D00136
D00136
,
D01898
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
86 | Haloperidol 2Mg Tab | 1件: Haloperidol Haloperidol | 2件: D00136
D00136
,
D01898
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
87 | High doses of Thiamine y Biotin | 2件: Biotin Biotin, Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
88 | HYPERIUM | 1件: Rilmenidine Rilmenidine | 1件: D08482
D08482
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 8 8 |
89 | Icosapent | 1件: Icosapent Icosapent | 1件: D08061
D08061
| - | - | 1件: 8 8 |
90 | Idebenone | 1件: Idebenone Idebenone | 1件: D01750
D01750
| - | - | 6件: 6 6, 8, 13, 18, 113, 302 |
91 | ISIS 443139 10 mg | - | - | - | - | 1件: 8 8 |
92 | ISIS 443139 120 mg | - | - | - | - | 1件: 8 8 |
93 | ISIS 443139 30 mg | - | - | - | - | 1件: 8 8 |
94 | ISIS 443139 60 mg | - | - | - | - | 1件: 8 8 |
95 | ISIS 443139 90 mg | - | - | - | - | 1件: 8 8 |
96 | Ketoconazole | 1件: Ketoconazole Ketoconazole | 1件: D00351
D00351
| 1件: CYP17A1 CYP17A1 💬 | 6件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 3件: 8 8, 13, 75 |
97 | LAQUINIMOD | 1件: Laquinimod Laquinimod | - | - | - | 4件: 8 8, 13, 49, 96 |
98 | Laquinimod capsules 0.5 mg | 1件: Laquinimod Laquinimod | - | - | - | 2件: 8 8, 96 |
99 | Latrepirdine | 1件: Latrepirdine Latrepirdine | 1件: D09917
D09917
| 6件: ACHE ACHE, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 22件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 8 8 |
100 | LAX-101 | 1件: LAX-101 LAX-101 | - | - | - | 1件: 8 8 |
101 | Lithium | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 5件: 2 2, 5, 6, 7, 8 |
102 | LMI070 | - | - | - | - | 2件: 3 3, 8 |
103 | LPM3770164 sustained release tablet | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 8 8 |
104 | LPM3770164 sustained release tablet simulant | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 8 8 |
105 | Melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
106 | Memantine | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 6, 8, 13, 49, 127, 205 |
107 | Metformin | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
108 | Minocycline | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
109 | Moderate doses of Thiamine y Biotin | 2件: Biotin Biotin, Thiamine | 2件: D00029
D00029
,
D08580
| - | - | 1件: 8 8 |
110 | N.a. | - | - | - | - | 10件: 3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 |
111 | Neflamapimod | 1件: Neflamapimod Neflamapimod | 1件: D10959
D10959
| 4件: MAPK11 MAPK11, MAPK12, MAPK13, MAPK14 💬 | 62件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬 | 1件: 8 8 |
112 | Nilotinib | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 6 6, 8, 34, 51, 86 |
113 | Nilotinib 150 MG | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 8 8 |
114 | OLANZAPINE | 1件: Olanzapine Olanzapine | 2件: D00454
D00454
,
D06623
| 11件: ADRA1A ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 8 |
115 | Omeprazole | 1件: Omeprazole Omeprazole | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 16件: 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
116 | OMS643762 | - | - | - | - | 1件: 8 8 |
117 | OSU6162 similar to (-)-OSU 6162 | - | - | - | - | 2件: 6 6, 8 |
118 | Other: 31-Phosphorus RMN Spectroscopy | 1件: Phosphorus Phosphorus | - | - | - | 1件: 8 8 |
119 | PBF-999 | - | - | - | - | 1件: 8 8 |
120 | PBF-999 / 160 mg | - | - | - | - | 1件: 8 8 |
121 | PBF-999 / 320 mg | - | - | - | - | 1件: 8 8 |
122 | PBT2 | - | - | - | - | 1件: 8 8 |
123 | PF-02545920 | - | - | - | - | 1件: 8 8 |
124 | PHENYLBUTYRATE | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 12件: 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
125 | Phosphorus | 1件: Phosphorus Phosphorus | - | - | - | 2件: 8 8, 238 |
126 | PL101 | - | - | - | - | 1件: 8 8 |
127 | Pridiopidine | - | - | - | - | 1件: 8 8 |
128 | Pridopidina | - | - | - | - | 1件: 8 8 |
129 | Pridopidine | 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 8 |
130 | Pridopidine (90 mg) | 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
131 | PRIDOPIDINE HYDROCHLORIDE | 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 8 8 |
132 | Quinidine | 1件: Quinidine Quinidine | 4件: D00642
D00642
,
D00643
,
D02272
,
D08458
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 2 2, 8, 13 |
133 | RAAV5-miHTT | - | - | - | - | 1件: 8 8 |
134 | Ramelteon | 1件: Ramelteon Ramelteon | 1件: D02689
D02689
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 8, 46 |
135 | Release | 1件: Manganese citrate Manganese citrate | - | - | - | 12件: 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
136 | Resveratrol | 1件: Resveratrol Resveratrol | - | - | - | 6件: 2 2, 8, 18, 89, 113, 299 |
137 | RG6042, formerly ISIS 443139, IONIS-HTTRx | - | - | - | - | 1件: 8 8 |
138 | Rilmenidine | 1件: Rilmenidine Rilmenidine | 1件: D08482
D08482
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 8 8 |
139 | RILUZOLE | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
140 | Risperidone | 1件: Risperidone Risperidone | 1件: D00426
D00426
| 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 5件: 8 8, 156, 179, 187, 206 |
141 | Risperidone 1Mg Tab | 1件: Risperidone Risperidone | 1件: D00426
D00426
| 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 1件: 8 8 |
142 | Ro 723-4292/F02 | - | - | - | - | 1件: 8 8 |
143 | RO7234292 | - | - | - | - | 1件: 8 8 |
144 | RO7234292 (RG6042) | - | - | - | - | 1件: 8 8 |
145 | Rolipram | 1件: Rolipram Rolipram | 1件: D01783
D01783
| 4件: PDE4A PDE4A, PDE4B, PDE4C, PDE4D 💬 | 5件: Metabolic pathways Metabolic pathways, Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 8 8, 13 |
146 | RP 103 | - | - | - | - | 2件: 8 8, 19 |
147 | RP103 | - | - | - | - | 2件: 8 8, 19 |
148 | SAGE-718 | - | - | - | - | 2件: 6 6, 8 |
149 | SBT-020 | - | - | - | - | 1件: 8 8 |
150 | SD-809 | - | - | - | - | 1件: 8 8 |
151 | Selisistat | 1件: Selisistat Selisistat | - | - | - | 1件: 8 8 |
152 | SEN0014196 | - | - | - | - | 1件: 8 8 |
153 | SEN0014196 (High Dose) | - | - | - | - | 1件: 8 8 |
154 | SEN0014196 (Low Dose) | - | - | - | - | 1件: 8 8 |
155 | Sodium phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 4件: 2 2, 3, 8, 251 |
156 | SOM3355 100mg BID | - | - | - | - | 1件: 8 8 |
157 | SOM3355 200mg BID | - | - | - | - | 1件: 8 8 |
158 | SRX246 | - | - | - | - | 1件: 8 8 |
159 | SS-20 | - | - | - | - | 1件: 8 8 |
160 | Tetrabenazine | 1件: Tetrabenazine Tetrabenazine | 1件: D08575
D08575
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
161 | Tetrabenazine withdrawal | 1件: Tetrabenazine Tetrabenazine | 1件: D08575
D08575
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
162 | Tetrahydrocannabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 4件: 8 8, 13, 36, 298 |
163 | THC | - | - | - | - | 5件: 8 8, 13, 36, 46, 96 |
164 | Thiamine | 1件: Thiamine Thiamine | 1件: D08580
D08580
| - | - | 4件: 8 8, 13, 93, 265 |
165 | Tiapridal | - | - | - | - | 1件: 8 8 |
166 | Tominersen | - | - | - | - | 1件: 8 8 |
167 | Triheptanoin | 1件: Triheptanoin Triheptanoin | 1件: D11465
D11465
| - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
168 | Triheptanoin 1g/kg/day | 1件: Triheptanoin Triheptanoin | 1件: D11465
D11465
| - | - | 1件: 8 8 |
169 | Triheptanoin oil | 1件: Triheptanoin Triheptanoin | 1件: D11465
D11465
| - | - | 1件: 8 8 |
170 | TV-5600 | - | - | - | - | 3件: 8 8, 13, 96 |
171 | TV-7820 | - | - | - | - | 1件: 8 8 |
172 | Ubiquinol | 1件: Ubiquinol Ubiquinol | - | - | - | 3件: 6 6, 8, 17 |
173 | Ursodiol | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 6件: 8 8, 20, 93, 97, 234, 299 |
174 | UX007 | - | - | - | - | 4件: 8 8, 248, 256, 257 |
175 | Valbenazine | 1件: Valbenazine Valbenazine | 1件: D10675
D10675
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
176 | Vitamin B7 | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 1件: 8 8 |
177 | VX-745 | - | - | - | - | 1件: 8 8 |
178 | VX15/2503 | - | - | - | - | 2件: 8 8, 13 |
179 | Warfarin | 1件: Warfarin Warfarin | 3件: D00564
D00564
,
D01280
,
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
180 | WVE-003 | - | - | - | - | 1件: 8 8 |
181 | WVE-120101 | - | - | - | - | 1件: 8 8 |
182 | WVE-120102 | - | - | - | - | 1件: 8 8 |
183 | Xenazine | 1件: Tetrabenazine Tetrabenazine | 1件: D08575
D08575
| 1件: SLC18A2 SLC18A2 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 8 8 |
184 | Zoloft 50Mg Tablet | - | - | - | - | 1件: 8 8 |